Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancer.
ENT-Department Friedrich-Schiller-University, Jena, Germany.
S
S
Koscielny
R
R
Dahse
J
J
Sonntag
U
U
Riese
C
C
Theuer
M E
ME
Hofmann
F
F
von Eggeling
U
U
Claussen
E
E
Beleites
G
G
Ernst
W
W
Fiedler
D018450:Disease Progression; D016147:Genes, Tumor Suppressor / Q000235:genetics; D019942:Genes, p16 / Q000235:genetics*; D006258:Head and Neck Neoplasms / Q000201:enzymology* / Q000235:genetics*; D006801:Humans; D011379:Prognosis; D019098:Telomerase / Q000235:genetics* / Q000378:metabolism*
D019098:Telomerase